Therapeutic Effects of Angiotensin (AT1) Receptor Antagonists: Potential Contribution of Mechanisms Other Than AT1 Receptor Blockade

Author： Boris Schmidt

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.4, Iss.6, 2004-01, pp. : 361-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential therapeutic targets for neurokinin-1 receptor antagonists

By Duffy Ruth A

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 9-21

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of protease-activated receptor-1 antagonists

By Derian Claudia K Maryanoff Bruce E Zhang Han-Cheng Andrade-Gordon Patricia

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 209-221

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of angiotensin II receptor antagonists

By White Michel Racine Normand Ducharme Anique Champlain Jacques de

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1687-1701

Informa Healthcare

Access to resources Recommend Favorite

Effects of angiotensin II and antagonists on AT 1 receptor expression in mesangial cells

By Chansel D. Vandermeersch S. Llorens-Cortes C. Ardaillou R.

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 223-230

Elsevier

Access to resources Recommend Favorite

Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity

By Kowalski Timothy J McBriar Mark D

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1113-1122

Informa Healthcare

Access to resources Recommend Favorite